10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,588,741 | +1358.7% | 499,121 | +1874.7% | 0.31% | +1547.4% |
| Q2 2023 | $1,411,412 | +61.0% | 25,276 | +60.9% | 0.02% | +26.7% |
| Q1 2023 | $876,461 | +137.6% | 15,710 | +55.2% | 0.02% | +114.3% |
| Q4 2022 | $368,846 | -47.6% | 10,122 | -59.0% | 0.01% | -41.7% |
| Q3 2022 | $704,000 | -97.3% | 24,702 | -95.6% | 0.01% | -97.4% |
| Q2 2022 | $25,679,000 | -54.6% | 567,487 | -23.7% | 0.46% | -12.4% |
| Q1 2022 | $56,579,000 | -50.4% | 743,781 | -3.0% | 0.52% | -19.5% |
| Q4 2021 | $114,167,000 | +0.8% | 766,428 | -1.5% | 0.65% | +10.7% |
| Q3 2021 | $113,224,000 | -25.6% | 777,747 | +0.1% | 0.59% | -21.4% |
| Q2 2021 | $152,118,000 | +7.5% | 776,825 | -0.6% | 0.75% | -2.1% |
| Q1 2021 | $141,476,000 | +25.4% | 781,635 | -1.9% | 0.76% | +36.2% |
| Q4 2020 | $112,806,000 | +31.4% | 796,655 | +15.7% | 0.56% | +5.9% |
| Q3 2020 | $85,856,000 | +85.2% | 688,611 | +32.6% | 0.53% | +45.7% |
| Q2 2020 | $46,367,000 | – | 519,168 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |